Dr. Henry Reis is a physician, author, editor and entrepreneur from Rio de Janeiro, Brazil; where he graduated from the University of Brazil (UFRJ), with a summa cum laude Ophthalmology degree. He is an active member of several medical associations, such as the Canadian Association of Ophthalmology, the International Society of Eye Research and the European Society of Cataract and Refractive Surgeons. He practices full-scope optometry in British Columbia since 2013.

During his extensive training in ophthalmology, he developed a special interest in cornea, cataract and glaucoma, and was actively involved in research, having published international papers on anterior segment disease and participated in studies such as the Lucentis International Trial for wet AMD.

Dr. Reis has lectured in Europe, North and South America, and his current research topics include tear osmolarity testing, IRPL and RF applications in dry eye disease and artificial intelligence for ocular surface disease diagnosis and  management. He is the Co-chair of the Cornea Section at the International Society of Eye Research Meeting in Australia and Faculty of the Canadian Dry Eye Summit.

Dr. Reis has developed a dry eye management algorithm in an effort to standardize and elevate the way dry eye disease is managed worldwide. He was the first practitioner in North America to use the E>Eye IRPL system in 2017 and also participated in its official launch in Brazil. Dr. Reis was also the first doctor to utilize a bipolar radiofrequency system for dry eye therapy in North America, participating in the study that allowed InModeMD to develop the world’s first RF ocular handpiece, the i-Forma. He introduced the Optimas platform in the eyecare market in 2018 and is was the first eye care provider to offer Lumecca, Forma and Morpheus8 treatments in Western Canada.

He is the Associate Editor of the CRO Journal and Senior Medical Advisor for I-MED Pharma, and a former member of the BCDO Areas of Practice Interest Committee and the EyeRecommend Member Engagement Committee. He has practiced as a consulting eyecare professional for Alcon, Bausch+Lomb, Hoya, Optos and Zeiss. Dr. Reis currently sits on the advisory board of I-Med Pharma, Allergan and Shire. Dr. Reis has also served as Vice-President of the BCDO Board of Directors and chair of the Provincial Telehealth Committee until February of 2017.

In addition to his involvement in ophthalmic education and practicing in a full-scope surgical corneal centre in Brazil, Dr. Reis is the CEO and co-founder of AI4Eyes, a Canadian-based medical device company that is developing the world’s first dry eye diagnostic device that uses artificial intelligence (AI) for anterior segment disease diagnosis and management.

Dr. Reis is the sole owner of the Integra Eye Care Network, which includes the award-winning, progressive, full-scope clinic in Burnaby, B.C founded in 2006 as well as the new, 3,000 sq. ft. state-of-the-art clinic in Vancouver, founded in 2023. Both clinics focus on innovative technology, outstanding patient care and doctor expertise.

Dr. Henry Reis is the winner of the 2020 Top Canadian Immigrant Award and the 2018 JnJ Top 40 under 40, and the recipient of the Silver Medal of Merit at the  111th Commonwealth Honour and Rescue Awards. In his spare time, Dr. Reis enjoys soccer, tennis, traveling and learning new languages. Dr. Reis is fluent in Portuguese, Spanish and English.